Vaccines

The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.

Data "shows the consequence of these vaccines and masks," said Dr. Fleming.

"I've heard people say it's common sense (to get vaccinated), but what about all the other countries that have taken it and still put people in lockdown," says local Ghanaian.

The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a third shot.

New hepatitis vaccine hit market in March—now CDC wants to remove "obstacle" of risk assessment before injecting patients with hepatitis vaccine.

Former Pfizer VP Michael Yeadon maintains that since the infection fatality ratio of COVID-19 has not been high, the vaccines should not have been mandated.

After getting called out for falsely stating that COVID-19 vaccines were not available when President Biden entered office last year, the White House has issued a tweet admitting the inaccuracy of its claim.

The Centers for Disease Control and Prevention (CDC) says it does not have documents backing its claim that COVID-19 vaccines do not cause variants of the virus that causes COVID-19.

In this interview, return guest Stephanie Seneff, Ph.D., a senior research scientist at MIT for over five decades, discusses the COVID-19 vaccines.

Good Morning America hosts questions what could bring the pandemic-related vaccine recommendations to a halt.